A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)

NCT00430495 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Atacicept
DRUG: Atacicept
DRUG: Atacicept
DRUG: Placebo matched to atacicept

Sponsor

EMD Serono

Collaborators

[object Object]